Gene Therapy with Enterovirus 3 C Protease: A Promising Strategy for Various Solid Tumors

Current cancer gene therapies rely primarily on antitumor immunity, but the exploration of alternative mRNA cargoes for direct antitumor effects is crucial to expand cancer gene therapies. Here we show that lipid nanoparticles (LNPs) carrying mRNA encoding a viral 3 C protease can efficiently suppress tumors by selectively inducing tumor cell apoptosis. In various solid tumor models, intracranial injection of LNPs carrying mRNA encoding the 3 C protease (3C-LNPs) significantly inhibits tumor growth and prolongs survival in glioblastoma models. Similarly, subcutaneous injection reduces tumor volume and inhibits angiogenesis in a breast cancer model, while intravenous injection inhibits tumor growth and angiogenesis and prolongs survival in hepatocellular carcinoma models. Mass spectrometry and cleavage site prediction assays identify heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) as the main target degraded by the 3 C protease. This study suggests that viral protease mRNA could be a promising broad-spectrum antitumor therapeutic.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-05-08
DOI
https://doi.org/10.1038/s41467-025-59440-8
Citations
1
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
1.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gene Therapy with Enterovirus 3 C Protease: A Promising Strategy for Various Solid Tumors

Ji‐Ye Yin, Yan Luo, X. L. Yan, Wu Zhong et al.
1 citations
Nature Communications
Virus-based gene therapy research
1.82
article

Gene Therapy with Enterovirus 3 C Protease: A Promising Strategy for Various Solid Tumors

Ji‐Ye Yin, Yan Luo, X. L. Yan, Wu Zhong, Qingsong Dai, Ruiyuan Cao, Sichen Ren, Li Song, Siqi Li, Ping Wang, Wei Li, Wenhao Zhang, Jingjing Yang, Zhuang Wang, Zhijie Chang, Weiyan Zhu, Shaokang Yang, Xiaotong Yang, Zhenyang Li, Jiazheng Li, Yuexiang Li, Chongda Luo, Huimin Tao, Xiaojia Guo, Yunfeng Shao
article en
1 citations

Abstract

Current cancer gene therapies rely primarily on antitumor immunity, but the exploration of alternative mRNA cargoes for direct antitumor effects is crucial to expand cancer gene therapies. Here we show that lipid nanoparticles (LNPs) carrying mRNA encoding a viral 3 C protease can efficiently suppress tumors by selectively inducing tumor cell apoptosis. In various solid tumor models, intracranial injection of LNPs carrying mRNA encoding the 3 C protease (3C-LNPs) significantly inhibits tumor growth and prolongs survival in glioblastoma models. Similarly, subcutaneous injection reduces tumor volume and inhibits angiogenesis in a breast cancer model, while intravenous injection inhibits tumor growth and angiogenesis and prolongs survival in hepatocellular carcinoma models. Mass spectrometry and cleavage site prediction assays identify heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) as the main target degraded by the 3 C protease. This study suggests that viral protease mRNA could be a promising broad-spectrum antitumor therapeutic.

Nature CommunicationsVol. 16(1)
National Institutes for Food and Drug Control (CN), Sanya University (CN), Tsinghua University (CN)
Good health and well-being
Openalex Percentile: Top 16%
Virus-based gene therapy research
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.